首页> 美国卫生研究院文献>Biophysical Journal >Direct inhibition of microtubule-based kinesin motility by local anesthetics.
【2h】

Direct inhibition of microtubule-based kinesin motility by local anesthetics.

机译:局麻药直接抑制基于微管的驱动蛋白运动。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Local anesthetics are known to inhibit neuronal fast anterograde axoplasmic transport (FAAT) in a reversible and dose-dependent manner, but the precise mechanism has not been determined. FAAT is powered by kinesin superfamily proteins, which transport membranous organelles, vesicles, or protein complexes along microtubules. We investigated the direct effect of local anesthetics on kinesin, using both in vitro motility and single-molecule motility assays. In the modified in vitro motility assay, local anesthetics immediately and reversibly stopped the kinesin-based microtubule movement in an all-or-none fashion without lowering kinesin ATPase activity. QX-314, a permanently charged derivative of lidocaine, exerted an effect similar to that of lidocaine, suggesting that the effect of anesthetics is due to the charged form of the anesthetics. In the single-molecule motility assay, the local anesthetic tetracaine inhibited the motility of individual kinesin molecules in a dose-dependent manner. The concentrations of the anesthetics that inhibited the motility of kinesin correlated well with those blocking FAAT. We conclude that the charged form of local anesthetics directly and reversibly inhibits kinesin motility in a dose-dependent manner, and it is the major cause of the inhibition of FAAT by local anesthetics.
机译:已知局麻药以可逆和剂量依赖的方式抑制神经元快速顺行性轴质运输(FAAT),但尚未确定确切的机制。 FAAT由驱动蛋白超家族蛋白驱动,该蛋白沿微管运输膜细胞器,囊泡或蛋白复合物。我们调查了局部麻醉药对驱动蛋白的直接作用,使用了体外运动性和单分子运动性试验。在改良的体外运动测定中,局部麻醉剂以可有可无的方式立即可逆地停止了基于驱动蛋白的微管运动,而不会降低驱动蛋白ATPase的活性。 QX-314是一种利多卡因的永久带电衍生物,其作用类似于利多卡因,这表明麻醉剂的作用是由于麻醉剂的带电形式。在单分子运动测定中,局部麻醉剂丁卡因以剂量依赖性方式抑制单个驱动蛋白分子的运动。抑制驱动蛋白运动性的麻醉剂浓度与阻断FAAT的麻醉剂浓度密切相关。我们得出结论,局部麻醉药的带电形式以剂量依赖的方式直接和可逆地抑制驱动蛋白的运动,这是局部麻醉药抑制FAAT的主要原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号